Phase 1 Malignant Solid Tumor Clinical Trials
40 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–20 of 40 trials
Recruiting
Phase 1
CT-95 in Advanced Cancers Associated With Mesothelin Expression
Colorectal, CancerMesothelin-Expressing TumorsEpithelial Ovarian Cancer+8 more
Context Therapeutics Inc.70 enrolled9 locationsNCT06756035
Recruiting
Phase 1Phase 2
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
Locally Advanced or Metastatic Malignant Solid Tumors
Astellas Pharma Global Development, Inc.428 enrolled7 locationsNCT07287995
Recruiting
Phase 1Phase 2
Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors
Advanced Solid TumorMalignant Solid Tumor
Daiichi Sankyo250 enrolled28 locationsNCT04145622
Recruiting
Phase 1
A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX43 in Advanced/Metastatic Solid Tumors
Advanced/Metastatic Malignant Solid Tumors
Shanghai Henlius Biotech367 enrolled10 locationsNCT06115642
Recruiting
Phase 1Phase 2
Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
Hepatocellular CarcinomaRefractory Solid TumorPediatric Solid Tumor+3 more
St. Jude Children's Research Hospital64 enrolled2 locationsNCT05468359
Recruiting
Phase 1Phase 2
A Study of TAK-505 in Adults With Solid Tumors
Malignant Solid Tumors
Takeda151 enrolled15 locationsNCT07436728
Recruiting
Phase 1Phase 2
A Study of MHB042C in Patients With Advanced Solid Tumors
Advanced Malignant Solid Tumor
Minghui Pharmaceutical (Hangzhou) Ltd200 enrolled1 locationNCT07192107
Recruiting
Phase 1Phase 2
A Study of MHB048C in Patients With Advanced Solid Tumors
Advanced Malignant Solid TumormCRPC (Metastatic Castration-resistant Prostate Cancer)
Minghui Pharmaceutical (Hangzhou) Ltd200 enrolled1 locationNCT07192120
Recruiting
Phase 1Phase 2
A Study of MHB009C in Patients With Advanced Solid Tumors
Advanced Malignant Solid Tumor
Minghui Pharmaceutical (Hangzhou) Ltd200 enrolled1 locationNCT07326488
Recruiting
Phase 1
Clinical Trial of IL - 22BP Safety, Tolerability, and Antitumor Activity in Refractory Solid Tumors.
Refractory Malignant Solid TumorsmRNA VaccineInterleukin
West China Hospital6 enrolled2 locationsNCT07040943
Recruiting
Phase 1
Trial to Assess the Safety and Antitumor Activity of GEN1057 in Malignant Solid Tumors
Advanced malignant solid tumorsMetastatic Malignant Solid Tumors
Genmab45 enrolled5 locationsNCT06573294
Recruiting
Phase 1
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2062 in Patients With Solid Tumors
Advanced Malignant Solid Tumor
Shanghai Virogin Biotech Co., Ltd.30 enrolled1 locationNCT07262164
Recruiting
Phase 1Phase 2
A Study of FC084CSA in Combination of Tislelizumab in Patients With Advanced Malignant Solid Tumors
Advanced malignant solid tumors
FindCure Biosciences (ZhongShan) Co., Ltd.33 enrolled1 locationNCT06499350
Recruiting
Phase 1
Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
Advanced Solid TumorMetastatic Solid TumorNon-small Cell Lung Cancer+6 more
Ankyra Therapeutics, Inc97 enrolled5 locationsNCT06171750
Recruiting
Phase 1
A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
Solid Tumor CancerAdvanced Malignant Solid Tumor
Pilatus Biosciences Inc36 enrolled2 locationsNCT07337525
Recruiting
Phase 1
Study of ISM6331 in Participants With Advanced/Metastatic Malignant Mesothelioma or Other Solid Tumors
Advanced Solid TumorMalignant MesotheliomaMetastatic Malignant Solid Tumor
InSilico Medicine Hong Kong Limited100 enrolled10 locationsNCT06566079
Recruiting
Phase 1Phase 2
An Early Phase Trial of RPTR-1-201 in Advanced Solid Tumors
Advanced Malignant Solid Tumor
Repertoire Immune Medicines150 enrolled1 locationNCT07293754
Recruiting
Phase 1
A Study of CSCJC3456 in Patients With Advanced Malignant Tumors
Advanced malignant solid tumors
Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd.102 enrolled2 locationsNCT06717750
Recruiting
Phase 1
A Study to Compare the Blood Levels and Safety of Tazemetostat in Participants With Advanced Cancer and Moderate/Severe Liver Impairment to Participants With Advanced Cancer and Normal Liver Function
Advanced Malignant Solid TumorHepatic Impairment
Epizyme, Inc.24 enrolled18 locationsNCT04241835
Recruiting
Phase 1Phase 2
A Phase I/II Clinical Study of SHR-1681 for Injection in Patients With Advanced Solid Tumors
Malignant Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.300 enrolled1 locationNCT06737731